Document is current
Any future updates will be listed below
-
Authors
Nguyen, Vi https://orcid.org/0000-0003-4363-5009
McGovern, Alysha M. https://orcid.org/0000-0002-6486-1788
Rojanasarot, Sirikan https://orcid.org/0000-0003-2102-7520
Patel, Darshan P. https://orcid.org/0000-0001-6866-7889
Bhattacharyya, Samir
Hargens, Liesl M. https://orcid.org/0009-0005-4714-2326
Aworunse, Olubiyi
Hsieh, Tung-Chin
- License Information
-
More Information
Article History
Received: 21 November 2023
Revised: 25 March 2024
Accepted: 3 May 2024
First Online: 26 June 2024
Competing interests
: VN has no disclosures. AMM has the following to disclose: Boston Scientific – Specialist, Health Economics, and Outcomes Research. SR has the following to disclose: Boston Scientific – Global Portfolio Lead, Health Economics, and Market Access. DPP has the following to disclose: Apta Pharma – Equity interest. Endo Pharmaceuticals – Advisor. SB has the following to disclose: Boston Scientific – Vice President, Health Economics and Market Access. LMH has the following to disclose: Boston Scientific – Vice President, Health Economics and Outcomes Research. OA has the following to disclose: Boston Scientific – Senior Manager, Health Economics and Market Access. TCH has the following to disclose: Boston Scientific – Advisor, consultant. Endo Pharmaceuticals – Advisor, consultant.
